Safety and efficacy of six months' open label extension post-RCT using the novel cathepsin K inhibitor MIV-711 in patients with knee osteoarthritis
| Autor: | Conaghan, P.G., Bowes, M.A., Kingsbury, S.R., Brett, A., Guillard, G., Thunblad, K., Larsson, T., Holmgren, Å., Manninen, A., Göhlin, K., Sjögren, N., Graham, P., Jansson, Å., Wadell, C., Bethell, R., Öhd, J. |
|---|---|
| Zdroj: | In Osteoarthritis and Cartilage April 2019 27 Supplement 1:S501-S502 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect